Dewhirst; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dewhirst; Mark.The latest application filed is for "x-ray psoralen activated cancer therapy (x-pact)".

Company Profile

6.12.14

Dewhirst; Mark - Durham NC
Dewhirst; Mark - Chapel Hill NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
X-ray Psoralen Activated Cancer Therapy (x-pact) App 20220226666 - Oldham; Mark ; et al.	2022-07-21
Methods, Compositions, And Kits For Treating And/or Preventing A Side Effect Associated With Radiation And/or Chemotherapy Exposure App 20220193090 - Ashcraft; Kathleen ; et al.	2022-06-23
X-ray psoralen activated cancer therapy (X-PACT) Grant 11,305,131 - Oldham , et al. April 19, 2	2022-04-19
Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure Grant 11,285,162 - Ashcraft , et al. March 29, 2	2022-03-29
X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments Grant 11,207,409 - Bourke, Jr. , et al. December 28, 2	2021-12-28
Methods, Compositions, And Kits For Treating And/or Preventing A Side Effect Associated With Radiation And/or Chemotherapy Exposure App 20210106594 - Ashcraft; Kathleen ; et al.	2021-04-15
Tumor Imaging With X-rays And Other High Energy Sources Using As Contrast Agents Photon-emitting Phosphors Having Therapeutic Pr App 20200222711 - WALDER; Harold ; et al.	2020-07-16
X-ray Psoralen Activated Cancer Therapy (x-pact) App 20200009398 - OLDHAM; Mark ; et al.	2020-01-09
X-ray psoralen activated cancer therapy (X-PACT) Grant 10,441,810 - Oldham , et al. Oc	2019-10-15
Biomarkers for locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC) Grant 10,253,367 - Reihani , et al.	2019-04-09
X-ray Psoralen Activated Cancer Therapy (x-pact) With Associated Treatments App 20180344850 - BOURKE, JR.; Frederic A. ; et al.	2018-12-06
Methods of identifying and using MDM2 inhibitors Grant 9,937,178 - Kornbluth , et al. April 10, 2	2018-04-10
Biomarkers of high-grade serous ovarian carcinomas Grant 9,771,620 - Reihani , et al. September 26, 2	2017-09-26
X-ray Psoralen Activated Cancer Therapy (x-pact) App 20170157418 - OLDHAM; Mark ; et al.	2017-06-08
Adhesive bonding composition and method of use Grant 9,649,832 - Fathi , et al. May 16, 2	2017-05-16
Adhesive Bonding Composition And Method Of Use App 20150246521 - FATHI; Zakaryae ; et al.	2015-09-03
Adhesive bonding composition and method of use Grant 9,023,249 - Fathi , et al. May 5, 2	2015-05-05
Manassatin compounds and methods of making and using the same Grant 8,946,289 - Hong , et al. February 3, 2	2015-02-03
Biomarkers Of High-grade Serious Ovarian Carcinomas App 20140342929 - Reihani; Sharareh ; et al.	2014-11-20
Methods Of Identifying And Using Mdm2 Inhibitors App 20140336202 - Kornbluth; Sally ; et al.	2014-11-13
Method Treating Breast Cancer App 20130039929 - Shenoy; Sudha ; et al.	2013-02-14
Adhesive Bonding Composition And Method Of Use App 20120089180 - Fathi; Zakaryae ; et al.	2012-04-12
Manassatin Compounds And Methods Of Making And Using The Same App 20110230540 - Hong; Jiyong ; et al.	2011-09-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.